861 related articles for article (PubMed ID: 29976470)
21. Watch and wait after a clinical complete response in rectal cancer patients younger than 50 years.
Bahadoer RR; Peeters KCMJ; Beets GL; Figueiredo NL; Bastiaannet E; Vahrmeijer A; Temmink SJD; Meershoek-Klein Kranenbarg WME; Roodvoets AGH; Habr-Gama A; Perez RO; van de Velde CJH; Hilling DE;
Br J Surg; 2021 Dec; 109(1):114-120. PubMed ID: 34738104
[TBL] [Abstract][Full Text] [Related]
22. [Rational evaluation of the complete response after neoadjuvant therapy in locally advanced mid-low rectal cancer: the pros and cons of "watch and wait" strategy].
Gu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):507-513. PubMed ID: 31238630
[TBL] [Abstract][Full Text] [Related]
23. Oncological and Survival Outcomes in Watch and Wait Patients With a Clinical Complete Response After Neoadjuvant Chemoradiotherapy for Rectal Cancer: A Systematic Review and Pooled Analysis.
Dattani M; Heald RJ; Goussous G; Broadhurst J; São Julião GP; Habr-Gama A; Perez RO; Moran BJ
Ann Surg; 2018 Dec; 268(6):955-967. PubMed ID: 29746338
[TBL] [Abstract][Full Text] [Related]
24. Is watch and wait a safe and effective way to treat rectal cancer in older patients?
Haak HE; Maas M; Lambregts DMJ; Beets-Tan RGH; Beets GL;
Eur J Surg Oncol; 2020 Mar; 46(3):358-362. PubMed ID: 31982206
[TBL] [Abstract][Full Text] [Related]
25. Oncologic outcomes of watch-and-wait strategy or surgery for low to intermediate rectal cancer in clinical complete remission after adjuvant chemotherapy: a systematic review and meta-analysis.
Tan S; Gao Q; Cui Y; Ou Y; Huang S; Feng W
Int J Colorectal Dis; 2023 Oct; 38(1):246. PubMed ID: 37787779
[TBL] [Abstract][Full Text] [Related]
26. Management and Outcome of Local Regrowths in a Watch-and-wait Prospective Cohort for Complete Responses in Rectal Cancer.
van der Sande ME; Figueiredo N; Beets GL
Ann Surg; 2021 Dec; 274(6):e1056-e1062. PubMed ID: 32039985
[TBL] [Abstract][Full Text] [Related]
27. Outcome and Salvage Surgery Following "Watch and Wait" for Rectal Cancer after Neoadjuvant Therapy: A Systematic Review.
Kong JC; Guerra GR; Warrier SK; Ramsay RG; Heriot AG
Dis Colon Rectum; 2017 Mar; 60(3):335-345. PubMed ID: 28177997
[TBL] [Abstract][Full Text] [Related]
28. [Total neoadjuvant therapy followed by watch and wait approach or organ preservation for MRI stratified low-risk rectal cancer: early result from a prospective, single arm trial].
Wang L; Zhao YM; Sun TT; Xu YL; Li SJ; Zhang XY; Cai Y; Li YH; Li ZW; Chen PJ; Peng YF; Wang WH; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):258-265. PubMed ID: 32192305
[No Abstract] [Full Text] [Related]
29. A meta-analysis of the watch-and-wait strategy versus total mesorectal excision for rectal cancer exhibiting complete clinical response after neoadjuvant chemoradiotherapy.
Yu G; Lu W; Jiao Z; Qiao J; Ma S; Liu X
World J Surg Oncol; 2021 Oct; 19(1):305. PubMed ID: 34663341
[TBL] [Abstract][Full Text] [Related]
30. Is the Management of Rectal Cancer Using a Watch and Wait Approach Feasible, Safe and Effective in a Publicly Funded General Hospital?
Kaul S; Rao C; Mane R; Tan KL; Khan AHA; Hussain MS; Shafi MA; Buettner F; Banerjee S; Boulton R; Bhargava A; Huang J; Hanson M; Raouf S; Ball S; Rajendran N
Clin Oncol (R Coll Radiol); 2022 Jan; 34(1):e25-e34. PubMed ID: 34454807
[TBL] [Abstract][Full Text] [Related]
31. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
[No Abstract] [Full Text] [Related]
32. Low rectal cancer treatment strategies: a cohort study assessing watch and wait.
Pinto JC; Pereira AD; Pimenta A; Pedro C; Fernandez G; Marques I; Miguel I; Freire J; Maciel J; Venâncio J; D'Orey L; Mirones L; Limbert M; Labareda M; Chaves P; Fonseca R; Barroca R; Ferreira T; Marques T; Rosa I
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2631-2638. PubMed ID: 32435893
[TBL] [Abstract][Full Text] [Related]
33. A Dynamic Clinical Calculator for Estimating Conditional Recurrence-Free Survival After Total Neoadjuvant Therapy for Rectal Cancer and Either Surgery or Watch-and-Wait Management.
Weiser MR; Chou JF; Kim JK; Widmar M; Wei IH; Pappou EP; Smith JJ; Nash GM; Paty PB; Cercek A; Saltz LB; Romesser PB; Crane CH; Garcia-Aguilar J; Schrag D; Gönen M
JAMA Netw Open; 2022 Sep; 5(9):e2233859. PubMed ID: 36173634
[TBL] [Abstract][Full Text] [Related]
34. Early results from implementation of a 'watch and wait' protocol for complete clinical response following chemoradiotherapy for rectal cancer.
Balasuriya HD; Timon C; Entriken F; Neely D; Herron J; Tang C; Van Hazel G; Warner MW
ANZ J Surg; 2022 Nov; 92(11):2961-2967. PubMed ID: 35841184
[TBL] [Abstract][Full Text] [Related]
35. Selected stage IV rectal cancer patients managed by the watch-and-wait approach after pelvic radiotherapy: a good alternative to total mesorectal excision surgery?
Custers PA; Hupkens BJP; Grotenhuis BA; Kuhlmann KFD; Breukink SO; Beets GL; Melenhorst J;
Colorectal Dis; 2022 Apr; 24(4):401-410. PubMed ID: 35060263
[TBL] [Abstract][Full Text] [Related]
36. Outcomes after the watch-and-wait strategy and local excision treatment for rectal cancer: a meta-analysis.
Li J; Ma Y; Wen L; Zhang G; Yao X
Expert Rev Anticancer Ther; 2023 May; 23(5):555-564. PubMed ID: 36795784
[TBL] [Abstract][Full Text] [Related]
37. Rectal cancer: Watch-and-wait and continuing the rectal-preserving strategy with local excision for incomplete response or limited regrowth.
Al-Najami I; Jones HJ; Dickson EA; Muirhead R; Deding U; James DR; Cunningham C
Surg Oncol; 2021 Jun; 37():101574. PubMed ID: 33853031
[TBL] [Abstract][Full Text] [Related]
38. Is neoadjuvant chemoradiation with dose-escalation and consolidation chemotherapy sufficient to increase surgery-free and distant metastases-free survival in baseline cT3 rectal cancer?
São Julião GP; Habr-Gama A; Vailati BB; Aguilar PB; Sabbaga J; Araújo SEA; Mattacheo A; Alexandre FA; Fernandez LM; Gomes DB; Gama-Rodrigues J; Perez RO
Eur J Surg Oncol; 2018 Jan; 44(1):93-99. PubMed ID: 29217398
[TBL] [Abstract][Full Text] [Related]
39. Observation of "complete clinical response" in rectal cancer after neoadjuvant chemoradiation: The Flinders experience.
Sposato LA; Lam Y; Karapetis C; Vatandoust S; Roy A; Hakendorf P; Dwyer A; de Fontgalland D; Hollington P; Wattchow D
Asia Pac J Clin Oncol; 2018 Dec; 14(6):439-445. PubMed ID: 29932278
[TBL] [Abstract][Full Text] [Related]
40. Systemic Chemotherapy as Salvage Treatment for Locally Advanced Rectal Cancer Patients Who Fail to Respond to Standard Neoadjuvant Chemoradiotherapy.
Sclafani F; Brown G; Cunningham D; Rao S; Tekkis P; Tait D; Morano F; Baratelli C; Kalaitzaki E; Rasheed S; Watkins D; Starling N; Wotherspoon A; Chau I
Oncologist; 2017 Jun; 22(6):728-736. PubMed ID: 28476941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
